Cargando…

Apatinib inhibits tumour progression and promotes antitumour efficacy of cytotoxic drugs in oesophageal squamous cell carcinoma

Apatinib, a highly selective inhibitor of vascular endothelial growth factor receptor‐2 (VEGFR‐2), inhibits the angiogenesis of tumours. The function and mechanism of apatinib in oesophageal squamous cell carcinoma (ESCC) remain unknown. In present study, we found that the development of ESCC in pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chi, Yanyan, Wang, Feng, Zhang, Yana, Shan, Zhengzheng, Tao, Weili, Lian, Yujin, Xin, Dao, Fan, Qingxia, Sun, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980885/ https://www.ncbi.nlm.nih.gov/pubmed/35315581 http://dx.doi.org/10.1111/jcmm.17209

Ejemplares similares

Antitumour effects of apatinib in progressive, metastatic differentiated thyroid cancer (DTC)
por: Shi, Liang, et al.
Publicado: (2022)

Reduced expression of Axin correlates with tumour progression of oesophageal squamous cell carcinoma
por: Nakajima, M, et al.
Publicado: (2003)

Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin
por: Wang, Feng, et al.
Publicado: (2017)

Oesophageal squamous cell carcinoma mimicking submucosal tumour
por: Wang, Wen, et al.
Publicado: (2021)

Local induction of a cytotoxic factor in a murine tumour by systemic administration of an antitumour polysaccharide, MGA.
por: Takahashi, K., et al.
Publicado: (1988)

miR‐516a‐3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway
por: Chi, Yanyan, et al.
Publicado: (2019)

Antitumour responses induced by short-term pretreatment with tumour cells.
por: James, K., et al.
Publicado: (1978)

Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
por: Gilabert-Oriol, Roger, et al.
Publicado: (2018)

Efficacy and safety of apatinib treatment for advanced esophageal squamous cell carcinoma
por: Li, Jianqiang, et al.
Publicado: (2017)

Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma
por: Li, Xiaofen, et al.
Publicado: (2018)

The miR-1224-5p/TNS4/EGFR axis inhibits tumour progression in oesophageal squamous cell carcinoma
por: Shi, Zhi-Zhou, et al.
Publicado: (2020)

Antitumour Antibiotics
por: Fox, B. W.
Publicado: (1979)

MiR‐130b promotes the progression of oesophageal squamous cell carcinoma by targeting SASH1
por: Zhu, Yuxing, et al.
Publicado: (2018)

Low levels of tumour suppressor miR-655 in plasma contribute to lymphatic progression and poor outcomes in oesophageal squamous cell carcinoma
por: Kiuchi, Jun, et al.
Publicado: (2019)

FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma
por: Miyazaki, T, et al.
Publicado: (2003)

Endothelin B receptor expression correlates with tumour angiogenesis and prognosis in oesophageal squamous cell carcinoma
por: Tanaka, T, et al.
Publicado: (2014)

Prevalence of Human Papillomavirus (HPV) in Oesophageal Squamous Cell Carcinoma in Relation to Anatomical Site of the Tumour
por: Löfdahl, Hedvig E., et al.
Publicado: (2012)

Oesophageal squamous cell carcinoma: histogram-derived ADC parameters are not predictive of tumour response to chemoradiotherapy
por: Kozumi, Maiko, et al.
Publicado: (2018)

Immunomodulatory and antitumour effects of abnormal Savda Munziq on S180 tumour-bearing mice
por: Aikemu, Ainiwaer, et al.
Publicado: (2012)

Case of oesophageal gastrointestinal stromal tumour
por: Łochowska, Barbara, et al.
Publicado: (2017)

Inhibition of Oesophageal Squamous Cell Carcinoma Progression by in vivo Targeting of Hyaluronan Synthesis
por: Twarock, Sören, et al.
Publicado: (2011)

Tristetraprolin inhibits macrophage IL-27-induced activation of antitumour cytotoxic T cell responses
por: Wang, Qinghong, et al.
Publicado: (2017)

Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin
por: Liu, Jian, et al.
Publicado: (2020)

STAT1 is regulated by TRIM24 and promotes immunosuppression in head and neck squamous carcinoma cells, but enhances T cell antitumour immunity in the tumour microenvironment
por: Anderson, Kelvin, et al.
Publicado: (2022)

Association between alcohol consumption and oesophageal microbiota in oesophageal squamous cell carcinoma
por: Rao, Wenqing, et al.
Publicado: (2021)

Antitumour activity of peroxidases.
por: Everse, K. E., et al.
Publicado: (1985)

The antitumour activities of statins
por: Takahashi, H.K., et al.
Publicado: (2007)

Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma
por: Hirashima, K, et al.
Publicado: (2012)

Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma
por: Chen, Liang, et al.
Publicado: (2020)

Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma
por: Zhao, Jian, et al.
Publicado: (2019)

Flasks, fibres and flanks – pre-clinical tumour models for predicting clinical antitumour activity
por: Newell, D R
Publicado: (2001)

Further studies on antitumour responses induced by short-term pretreatment with syngeneic tumour cells.
por: James, K., et al.
Publicado: (1979)

Antitumour activity of adenovirus-12 structural proteins against Moloney sarcoma tumours in mice.
por: Abid, S. H., et al.
Publicado: (1976)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
por: Zhang, Weihua, et al.
Publicado: (2021)

Rare oesophageal tumours: experience of one centre
por: Zielinski, J., et al.
Publicado: (2012)

Hydropneumopericardium: A Rare Complication of an Oesophageal Tumour
por: Rodrigues Morais, Joana, et al.
Publicado: (2022)

Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors
por: Ferlini, C, et al.
Publicado: (2000)

Application effect of apatinib in patients with failure of standard treatment for advanced malignant tumours
por: Liu, Guohui, et al.
Publicado: (2019)

Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy
por: Su, Po-Jung, et al.
Publicado: (2016)

Association of tumour-associated macrophages with cancer cell EMT, invasion, and metastasis of Kazakh oesophageal squamous cell cancer
por: Liu, Jihong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_geehedvghannudnaf6sjtad8t2